The NF-κB pathway’s role in GPS inflammation parallels its activation in doxorubicin-induced cardiotoxicity (endothelial dysfunction) and osteosarcoma (cell growth promotion) (Chen F. et al., 2018; Xiao et al., 2020). Here, NFKB1 is linked to osteosarcoma.